Cette journée a eu lieu le vendredi 16 octobre 09, au Musée des Moulages de l’Hôpital Saint-Louis à Paris, 1 avenue Claude vellefaux, 75010.
Le programme est le suivant :
8h30 : Accueil des congressistes
9h00-9h10 : INTRODUCTION - Louis Dubertret
9h10-9h30 : PSORIASIS, GROSSESSE ET CONTRACEPTION - Selim Aractingi
9h40-10h00 : PARTICULARITES DU PSORIASIS DE L’ENFANT - Christine Bodemer
10h00-10h30 : QUAND LE PSORIASIS MET LA VIE EN DANGER - Hervé Bachelez
10h40-11h00 : Pause
11h00-11h20 : PSORIASIS ET EDUCATION THERAPEUTIQUE - Carle Paul
11h30-12h10 : CAS CLINIQUES INTERACTIFS - Catherine Goujon, Michel Le Maître
12h10-13h30 : Déjeuner
13h30-13h50 : EVALUATION DES RISQUES CARDIOVASCULAIRES CHEZ UN PSORIASIQUE - Alain Simon
14h00-14h20 : UTILISATION AU LONG COURS DES TRAITEMENTS ANTI-PSORIASIQUES - Louis Dubertret
14h30-14h50 : LES NOUVELLES CIBLES THERAPEUTIQUES DANS LE PSORIASIS - Martine Bagot
15h00-15h20 : LES BIOTHERAPIES EN PRATIQUE - Catherine Goujon
15h30-15h50 : Pause
15h50-17h00 : CAS CLINIQUES INTERACTIFS (SUITE) - Marie Beylot-Barry, François Aubin, Vincent Descamps
Contact : Christina Pitton - Groupe Français du Psoriasis
Hôpital Saint-Louis, Pavillon Bazin
1 avenue Claude Vellefaux, 75010 Paris
Tel : 01 53 72 20 60 - Fax : 01 53 72 20 61
email : clubfrancaisdupsoriasis@gmail.com
www.psoriasis-international.org/gfp
Les résumés de la journée sont accessibles en cliquant ici
L’accès aux diaporamas des différentes conférences est restreint, inscrivez-vous pour y avoir accès.
SPIN Presentation
Recent news
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
- 2019/04/18 Focus on...
- 2019/04/17 Focus on...
- 2018/07/16 Focus on...
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Aliment. Pharmacol. Ther..
2019 Aug , 50, (3):289-294.
Anti-TNFα agents have revolutionised management of chronic inflammatory diseases. Paradoxically, these agents might provoke development of de novo autoimmune diseases.
see on pubmed
Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIγ expression in keratinocytes.
Biochem. Biophys. Res. Commun..
2019 Aug 06, 515, (4):665-671.
Psoriasis is a chronic inflammatory skin disease characterized by keratinocyte hyperproliferation. Ginsenoside compound K (CK), a bioactive metabolite of ginseng, modulates various skin disorders with an impact on keratinocyte biology. However, the effect of Ginsenoside CK in psoriasis has not been explored.
see on pubmed
A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (TNF-α inhibitor) therapy.
J. Theor. Biol..
2019 Aug 07, 474:63-77.
Psoriasis is a chronic skin condition that produces plaques of condensed, scaling skin due to excessively rapid proliferation of keratinocytes. During the disease progression, keratinocyte proliferation is influenced by many immune cells and cytokines. This article deals with a five dimensional deterministic model, which has been derived using quasi-steady-state approximation for describing the dynamics of psoriasis in various cytokines environment. Equilibrium analysis of the system shows (...)
see on pubmed
on Atopic Dermatitis
Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.
Campbell M et al.
Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.
J Ethnopharmacol.
2019 Sep 15, 241:111955.
Rhamnus prinoides (gesho) is an evergreen shrub from East Africa traditionally used for the treatment of illnesses including atopic dermatitis, ear, nose and throat infections, pneumonia, arthritis, brucellosis, flu, indigestion and fatigue.
see on pubmed
Gardenia jasminoides extract without crocin improved atopic dermatitis-like skin lesions via suppression of Th2-related cytokines in Dfe-induced NC/Nga mice.
J Ethnopharmacol.
2019 Sep 15, 241:112015.
Atopic dermatitis (AD) is a pruritic, chronic, relapsing inflammatory skin disease. Gardenia jasminoides extract (GJE) has been used as a traditional remedy for the treatment of various inflammatory diseases, including AD. The specific effects of the extract components, which include crocin, geniposidic acid, and gardenoside, on inflammatory responses in AD are not entirely (...)
see on pubmed
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
Choi EJ et al.
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
J Enzyme Inhib Med Chem.
2019 Dec , 34, (1):613-619.
This study aimed to evaluate the effects of cinnamamides on atopic dermatitis (AD) and the mechanisms underlying these effects. To this end, the actions of two cinnamamides, (E)-3-(4-hydroxyphenyl)-N-phenylethyl acrylamide (NCT) and N-trans-coumaroyltyramine (NCPA), were determined on AD by orally administering them to mice. Oral administration of the cinnamamides ameliorated the increase in epidermal and dermal thickness as well as mast cell infiltration. Cinnamamides suppressed serum (...)
see on pubmed
